Neuroendocrine Cancer UK has been made aware that there is an imminent issue regarding the availability of Olatuton® (Octreotide long-acting) somatostatin analogue injections. This is due to a legal issue that has led to the withdrawal of Olutaton®: it will not be...
The presence and/or treatment of Neuroendocrine Cancer can disrupt normal digestive function – this can impact on our ability to absorb nutrients, including vitamins and minerals, from the food we eat. Malnutrition has been reported in up to 40% of...
There are a number of treatments available for Neuroendocrine Cancer – but your treatment should be based on your Neuroendocrine Cancer, your general health and your informed choice. Find out more here –...
There are a number of treatments available for Neuroendocrine Cancer – but your treatment should be based on your Neuroendocrine Cancer, your general health and your informed choice. You can find out more about treatments in Neuroendocrine Cancer here ➡️...
A publication on the prevalence of self-reported side effects in neuroendocrine tumour patients prescribed somatostatin analogues written by Catherine Bouvier, Tara Whyand and Philippa Davies was featured in the British Journal of Nursing in 2018. Somatostatin...
